3,4-Diaminopyridine Dimer Detection via HPLC
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need for sensitive methods to detect and quantify impurities and degradation in 3,4-diaminopyridine samples, as impurities can cause adverse effects and affect the efficacy of the drug, and existing methods are inadequate for assessing the purity and degradation of this pharmaceutical compound.
Innovation Solution
The method involves using high-performance liquid chromatography (HPLC) to identify and quantify the presence of a dimer of 3,4-diaminopyridine, specifically in the form of a salt, solvate, or complex, such as 3,4-diaminopyridine dimer sulfate monohydrate monomethanolate, which serves as a reference marker for determining sample purity and degradation, and synthesizing this dimer for use in chromatographic analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If high-performance liquid chromatography is used to detect and quantify degradation products, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent uses a reference marker (authentic degradation product) as an intermediary substance to enable precise detection and quantification of degradation products. This reference marker serves as a mediator between the complex HPLC system and the degradation products, allowing for accurate identification and measurement without directly complicating the detection process
Solution Approach 2:
The patent employs parameter changes by optimizing HPLC conditions (mobile phase composition, flow rate, detection wavelength) to enhance the detection sensitivity for degradation products. By adjusting these parameters, the system achieves high measurement precision while managing the inherent complexity of the chromatographic system
2Manufacturing precision
If a reference marker method is implemented for quantitation, then manufacturing precision is improved, but ease of manufacture deteriorates
Solution Approach 1:
The patent applies preliminary action by synthesizing and characterizing the degradation product (reference marker) in advance before the actual quality control analysis. This pre-prepared reference marker enables accurate quantitation during routine testing without requiring complex on-demand synthesis procedures
Solution Approach 2:
The patent uses a copied structure approach by creating an authentic copy of the degradation product (reference marker) that mirrors the actual impurity found in the drug substance. This copied reference compound serves as a standard for comparison, enabling precise quantitation while simplifying the manufacturing process compared to developing new analytical methods for each sample
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for accurate detection and quantitation of impurities and degradation in 3,4-diaminopyridine samples, ensuring the quality and therapeutic effectiveness of the drug by providing a standardized metric for assessing purity and monitoring shelf life.
Implementation Method 1
subjecting the sample to high performance liquid chromatography to identify the presence or absence of a peak identified as a dimer of 3,4-diaminopyridine
Data Source
AI summary
The present invention relates to methods of determining the purity of a sample of 3,4-diaminopyridine comprising determining the presence, absence, or amount of a dimer of 3,4-diaminopyridine or a dimer of 3,4-diaminopyridine in the form of a salt, solvate or complex or a combination thereof. The invention also relates to methods of detecting and quantitating degradation in a sample of 3,4-diaminopyridine. Dimers of 3,4-diaminopyridine and methods of making and isolating the same are also provided.